GENE ONLINE|News &
Opinion
Blog

2021-05-31| R&DTechnology

Novel CRISPR Screen Unravels Disease-Related Genes in Neurons

by Sahana Shankar
Share To

From a gene-editing tool that could edit a single gene, CRISPR has evolved to switch on or off. Recent improvements to scale-up editing capabilities have focused on how multiple edits could be performed on multiple genes simultaneously to understand their interconnectivity in the function of a cell.

To that end, researchers from the University of California, San Francisco, have developed a new technique to screen genes important for the development and survival of a cell type by separately turning on/off each gene with genome-wide CRISPR. These changes are temporary and reversible and hence allow us to study disease-related environments.

The study, published in Nature Neuroscience, focused on identifying genes associated with neurodegenerative diseases like Alzheimer’s and dementia. The authors performed a gain-of-function CRISPRa screen on human stem cell-derived neurons to activate/overexpress one gene at a time.

 

Uncovering Genes Essential for Neuronal Function and Survival

This study, in tandem with their previous report where they established a loss-of-function CRISPRi screen to switch off genes, uncovered a list of genes essential for neuronal function and survival. Strikingly, the top 10 genes that caused toxicity in the CRISPRi screen were inhibitors of oxidative stress, and top hits in the CRISPRa screen were apoptotic genes with minimal overlap between CRISPRi and CRISPRa hits.

Neurodegeneration results from severe oxidative stress in neurons. Hence, the team looked at genes that caused a buildup of reactive oxygen species (ROS) in the cells or destabilized the redox balance in the neurons. The authors validated the mechanistic basis for one of the hits, PSAP, a gene that codes for prosaposin, a lysosomal protein.

Investigating the levels of ROS and lipid peroxidation in PSAP KO lines, they demonstrated that loss of PSAP causes oxidative stress leading to neuronal ferroptosis, an indication of aging. Further studies showed that this PSAP-related ROS pathway was specific for neurons and is mediated by the accumulation of lipofuscin.

By grouping the top hits from the screens and selecting those with previously reported association to neurodegeneration, the authors performed a secondary screen to reveal clusters of genes that shared transcriptomic profiles, which could help understand the interconnected regulation in genes.

 

CRISPRbrain Database

This study was the first to screen genes in differentiated human neurons. The authors have made all the data from these functional genomic screens publicly available in a database called CRISPRbrain. The team intends to repeat such screens in other brain cell types such as astrocytes and glia to look further into the genetic basis of neurodegeneration.

In a press release, lead author Martin Kampmann, Ph.D., Associate Professor, Institute for Neurodegenerative Diseases and the UCSF Weill Institute for Neurosciences, noted that “This is the key next step in uncovering the mechanisms behind disease genes.”

The genome-wide CRISPRi/CRISPRa screen could help understand the systemic role of genes and their expression levels with cell type and tissue specificity. At the intersection of gene sequencing, stem cell, and CRISPR technologies, such studies can help uncover the mechanisms behind genetic diseases and are especially useful in dissecting multigenic disorders such as cancer.

Related Article: New Technique Could Challenge CRISPR by Editing Millions of DNA Sites Simultaneously

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
BIO 2022: Addressing Bottlenecks in Gene Therapy
2022-08-03
Billions of Research Dollars May Have Been Wasted Due to Fraudulent Alzheimer’s Study
2022-07-26
Roche Bags Fast Track Label for New Alzheimer’s Diagnostic
2022-07-21
LATEST
Pfizer Acquires Global Blood Therapeutics and its sickle cell disease expertise for $5.4 billion
2022-08-09
GSK Puts Up $100 Million for Mersana’s HER2-Targeting ADC Candidate
2022-08-09
Bio Asia 2022: The Future Of CGT In Taiwan
2022-08-08
Karuna Therapeutics Announces Topline Results from Schizophrenia Therapy Clinical Trial
2022-08-08
Three Previously Approved Treatments Show Anti-monkeypox Activity
2022-08-08
Myovant, Pfizer’s Endometriosis Pain Treatment Gets FDA Greenlight
2022-08-08
Pfizer Reportedly in Talks of $5 Billion Global Blood Therapeutics Purchase
2022-08-08
EVENT
2022-09-09
ESMO 2022 Exhibition
Online and on-side
2022-09-20
Cell & Gene Therapy USA 2022
Virtual
2022-09-21
CSCO Educational Book 2022
Xiamen
2022-09-21
RESI Boston
Boston
2022-09-26
Human Gene Therapy Conference
Australia
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!